Clinical trial
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in…
NCT00089180 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00089180 |
|---|---|
| Title | T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant |
| Official title | A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Actinic Keratosis, Basal Cell Carcinoma of the Skin, Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin |
| Intervention type | Drug, Other |
| Interventions | liposomal T4N5 lotion, placebo, laboratory biomarker analysis |
| Enrollment | 100 |
| Start date | Mar 1, 2004 |
| Primary completion | Jan 1, 2007 |
| First posted | Aug 5, 2004 |
| Last update posted | Dec 4, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: